Gaucher’s Disease – in the news!

29 Jan by Carrie

Amicus Therapeutics, Inc. (FOLD) Announces Fourth Quarter and Year End 2008 Financial Results Release Date
…Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

~ Filed Under: Gaucher's Disease

Comments

  1. Davida says:
    01/29/2009 at 10:39 pm

    I’m so thankful for modern medicine! The strides they make in research these days help save many lives and make those lives more comfortable. I hope Amicus’ clinical trials are a major success for the treatment of Gaucher disease.

    Hannah looks so happy and lovable in her pic.

    Davida

  2. DhoyM says:
    01/29/2009 at 11:11 pm

    Hi, Hannah is so adorable.